Analysed SCINAI IMMUNOTHERAPEUTICS LT (SCNI:NASDAQ) News Sources
Scinai Announces Completion of Acquisition of Recipharm Israel Ltd. and Strategic Commercial Collaboration with Recipharm
17-02-2026
yahoo.com
Scinai Announces Expanded Israel Innovation Authority Support for Robotic Aseptic Fill & Finish Platform
25-02-2026
yahoo.com
Scinai Signs Second Amendment to PinCell Option Agreement and Submits Revised €12 Million Non-Dilutive FENG Application to Advance PC111 Through Human Proof of Concept
02-03-2026
yahoo.com
Scinai Immunotherapeutics Receives Nasdaq Notification Regarding Minimum Bid Price
16-03-2026
yahoo.com
Scinai Immunotherapeutics Highlights Expanded CDMO Platform and Immunology Pipeline at BIO-Europe Spring® 2026
19-03-2026
yahoo.com
Scinai Reports Full-Year 2025 Results, with CDMO Revenues Doubling and Strategic Expansion Through Recipharm Collaboration
01-04-2026
yahoo.com
Scinai Completes Strategic Reorganization to Establish Dedicated CDMO Platform and Lean R&D Structure; Outlines 2026 Priorities
06-04-2026
yahoo.com
Scinai Immunotherapeutics to Lead Strategic Roundtable Discussion on Oral Therapies and the Future of Biologics at the 7th Dermatology Drug Development Summit Europe
15-05-2026
yahoo.com
What is the current price of SCINAI IMMUNOTHERAPEUTICS LT (SCNI:NASDAQ)?
The current price of SCINAI IMMUNOTHERAPEUTICS LT (SCNI:NASDAQ) is $0.4494.
SCINAI IMMUNOTHERAPEUTICS LT (SCNI:NASDAQ) absolute price change since previous trading day?
The absolute price change of SCINAI IMMUNOTHERAPEUTICS LT (SCNI:NASDAQ) since the previous trading day is $0.0015.
SCINAI IMMUNOTHERAPEUTICS LT (SCNI:NASDAQ) percentage price change since previous trading day?
The percentage price change of SCINAI IMMUNOTHERAPEUTICS LT (SCNI:NASDAQ) since the previous trading day is 0.3349%.
What is the most recent average sentiment score for SCINAI IMMUNOTHERAPEUTICS LT (SCNI:NASDAQ)?
The most recent average sentiment score for SCINAI IMMUNOTHERAPEUTICS LT (SCNI:NASDAQ) is 72 out of 100.
What is the most recent average sentiment for SCINAI IMMUNOTHERAPEUTICS LT (SCNI:NASDAQ)?
The most recent sentiment for SCINAI IMMUNOTHERAPEUTICS LT (SCNI:NASDAQ) is .
SEC-8K** Filing Available For SCINAI IMMUNOTHERAPEUTICS LT (SCNI:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.